Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20142
20172
20181
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.3
CTI BioPharma2
AO GENERIUM1
AOP Orphan Pharmaceuticals AG1
Amgen1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Seagen Inc.1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases11
Bone Marrow Diseases6
Anemia4
Lymphoma3
Lymphoma, B-Cell3
Lymphoma, Non-Hodgkin3
Myeloproliferative Disorders3
Polycythemia Vera3
Primary Myelofibrosis3
Splenomegaly3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.